Published in Clin Exp Immunol on October 01, 1974
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes. Immunology (1976) 2.06
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Control of the immune response. I. Depression of DNA synthesis by immune lymph node cells. Immunology (1975) 1.29
Specific adsorption of IgM antibody onto H-2-activated mouse T lymphocytes. J Exp Med (1976) 1.26
Spleen cell changes during fatal and self-limiting malarial infections of mice. Immunology (1978) 1.08
Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses. Infect Immun (1978) 1.01
Different rosette assays for detecting Fc receptor-bearing lymphocytes measure different subpopulations. Immunology (1978) 1.00
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Evidence for antibody-dependent cell-mediated cytotoxicity by T cells bearing receptors for IgG. Clin Exp Immunol (1979) 0.93
Autoimmune New Zealand mouse. Alterations in C3 receptors, complement-induced clumps and follicular adherence of immune complexes. Immunology (1975) 0.90
Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells. Immunology (1976) 0.86
Transfer of immunity against Listeria monocytogenes by T cells purified by a positive selection technique. Infect Immun (1978) 0.85
Complementation of the plaque-forming cell responses of T-cell-deficient nude mice by a T-cell hybridoma. Proc Natl Acad Sci U S A (1981) 0.80
Release and reconstitution of Fc receptors from normal human mononuclear cells. Immunology (1980) 0.79
Complement-induced mixed aggregation of T and B lymphocytes and myeloid cells and the effect of adjuvant. Clin Exp Immunol (1975) 0.78
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand J Immunol (1972) 4.50
Isolation and partial characterization of lymphocyte surface immunoglobulins. J Exp Med (1972) 4.04
Ca++-dependent binding of antigen-19 S antibody complexes to macrophages. J Immunol (1969) 3.70
The morphology of immune reactions in normal, thymectomized and reconstituted mice. II. The response to oxazolone. Immunology (1969) 2.69
Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte? Clin Exp Immunol (1973) 2.53
Monospecificity of bone marrow-derived lymphocytes. J Exp Med (1973) 1.74
Cell surface-associated gamma globulins in lymphocytes. IV. Lack of detection of surface globulin on B-cells and acquisition of surface G globulin by T-cells during primary response. J Immunol (1972) 1.45
The binding of human IgG subclasses to human monocytes. Eur J Immunol (1972) 1.38
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol (1973) 1.28
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Receptor for monomeric IgM on guinea-pig splenic macrophages. Nature (1973) 1.10
The detection and production of macrophage cytophilic antibody to different antigens in different laboratory animals. Immunology (1971) 0.90
Reaginic antibodies on basophils in grass pollen allergy, as shown by rosette-formation. Int Arch Allergy Appl Immunol (1972) 0.84
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Immunity to malaria. Br Med Bull (1982) 1.34
Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34
Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Two distinct types of non-specific immunosuppression in murine malaria. Clin Exp Immunol (1980) 1.14
Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13
B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09
Macrophages as effector cells in immunity to malaria. Immunol Lett (1985) 1.09
Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol (1984) 1.06
Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro. Clin Exp Immunol (1982) 1.05
Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol (1983) 1.04
Cooperation by mouse T lymphocytes: the role of antibody in T cell specificity. Eur J Immunol (1974) 1.03
Failure of malaria vaccination in mice born to immune mothers. Clin Exp Immunol (1982) 1.03
Early maturation of immune responses in neonatal New Zealand black (NZB) mice. Proc R Soc Med (1967) 1.02
Hyper-responsiveness in NZB mice to the experimental induction of anti-red cell autoantibody. Clin Exp Immunol (1977) 1.02
Antilymphocyte autoantibody in lethal mouse malaria and its suppression by non-lethal malaria. Parasite Immunol (1983) 1.02
Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infect Immun (1994) 1.01
Polyclonal in vitro proliferative responses from nonimmune donors to Plasmodium falciparum malaria antigens require UCHL1+ (memory) T cells. Eur J Immunol (1990) 1.01
Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun (1987) 1.01
Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax. Infect Immun (1992) 1.01
Malaria: toxins, cytokines and disease. Parasite Immunol (1995) 1.01
Failure of malaria vaccination in mice born to immune mothers. II. Induction of specific suppressor cells by maternal IgG. Clin Exp Immunol (1983) 1.00
Cross-reactions between erythrocytes at the T-cell level. Immunology (1973) 0.99
Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria. Exp Parasitol (1977) 0.99
Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res (1989) 0.98
B cell-derived immunoglobulin on activated mouse T lymphocytes. Nature (1974) 0.97
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun (1996) 0.96
Phospholipid-containing toxic malaria antigens induce hypoglycaemia. Clin Exp Immunol (1992) 0.96
Serum IL-2 inhibitor in mice. II. Molecular characteristics. Immunology (1985) 0.96
Development and suppression of a population of late-adhering macrophages in mouse malaria. Parasite Immunol (1979) 0.96
Differential tolerance of thymus-independent and thymus-dependent antibody responses. Immunology (1978) 0.96
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Deficient cell-mediated immunity in adult NZB mice. Transplantation (1970) 0.95
Interferon-gamma as an adjuvant in immunocompromised mice. Immunology (1989) 0.95
Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum. Parasite Immunol (1993) 0.93
Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol Genet Metab (2001) 0.92
Effective and ineffective immune responses to parasites: evidence from experimental models. Curr Top Microbiol Immunol (1978) 0.92
The role of T cells in regulating immunoglobulin class and subclass. Immunology (1980) 0.92
A novel adjuvant for use with a blood-stage malaria vaccine. Vaccine (1995) 0.91
Blood-stage malaria infection in diabetic mice. Clin Exp Immunol (1995) 0.91